BioLineRx Names Philip A. Serlin as Chief Executive Officer
Go back to BioLineRx Names Philip A. Serlin as Chief Executive Officer| Bioline RX Ltd Ordinary shares (AMEX: BLNEF) | Delayed: 0.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.86 | 52 Week High | $1.54 | |||
| Open | $1.64 | 52 Week Low | $1.15 | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.86 | EPS | $0.00 | |||
| Volume | 1,500 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.76 +0.04 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.72 | 52 Week High | $1.63 | |||
| Open | $2.70 | 52 Week Low | $0.71 | |||
| Day High | $2.76 | P/E | N/A | |||
| Day Low | $2.69 | EPS | $0.00 | |||
| Volume | 3,076 | |||||
| (NASDAQ: VBLT) | Delayed: 0.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.16 | 52 Week High | $7.58 | |||
| Open | $45.66 | 52 Week Low | $2.76 | |||
| Day High | $0.16 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $0.00 | |||
| Volume | 367 | |||||

